Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves elements of artificial vision system for blind patients ➤ Expanded indication for MIGS device ➤ 5-year pivotal trial data for MIGS device ➤ Topline results from Phase 2 study of investigational MGD treatment
➤ FDA accepts NDA for fixed-combination mydriatic agent ➤ NDA accepted by FDA for dry eye nasal spray ➤ NDA submitted for drop to treat presbyopia ➤ Study to assess outcomes of ab interno canaloplasty ➤ Largest study of glaucoma genetics published ➤ Iridex and Topcon enter into strategic agreement ➤ COVID-19 vaccine update ➤ ASCRS Journal Club on March 11
➤ PMA submitted to FDA for small-aperture IOL ➤ Preclinical results for new class of non-prostaglandin analogs for IOP lowering ➤ A Phase 2 clinical trial begins enrollment for topical presbyopia-correcting drop ➤ Home OCT technology used in clinical trial to reduce participant visits to offices ➤ ASCRS Journal Club on March 11
➤ Investigating adjuvant therapy to DSO for Fuchs ➤ FDA approves loteprednol etabonate ophthalmic gel ➤ Pilot study: Photobiomodulation improves BCVA in patients with dry AMD ➤ Positive interim data in trial for gene therapy for GA ➤ Four Phase 3 studies of faricimab show up to 4-month treatment intervals for DME and wet AMD
➤ NDA filed for topical glaucoma and ocular hypertension ophthalmic solution ➤ Nepafenac vs. placebo, results from Phase 2 study ➤ Enrollment completed for photobiomodulation treatment trial ➤ ASCRS activity updates
➤ 2021 ASCRS Annual Meeting update ➤ FDA approves new monofocal IOL ➤ First patient dosed in Phase 2 trial for investigational DED therapy ➤ Phase 2a trial initiated for add-on wet AMD therapy
➤ Topline results from Phase 3 studies for nAMD treatment ➤ Phase 2 trial of betamethasone treatment for cataract surgery pain and inflammation ➤ Fast Track designation given to therapy seeking to treat achromatopsia ➤ Topline data from Phase 1 trial of travoprost intracameral implant ➤ ASCRS Journal Club
➤ Enrollment complete for Phase 3 studies of investigational dry eye drug ➤ Update from two Glaukos trials ➤ Study: Remote monitoring with implantable IOP sensor affects clinical decision making ➤ ASCRS events
➤ Success with first-in-human implant of new artificial cornea ➤ Launch of first longitudinal study for home OCT ➤ Enrollment complete for study evaluating treatment for Leber congenital amaurosis 10 ➤ Phase 1/2a trial for wet AMD treatment with suprachoroidal injection begins enrollment ➤ Fast Track designation issued for investigational dry AMD therapy
➤ Commercial launch of Alcon’s Vivity IOL ➤ Topline results from Phase 2 trial for treatment of contact lens discomfort ➤ Company registers new artificial intelligence visual field exam device with FDA ➤ Positive Phase 3 results for faricimab for DME ➤ Research begins to create a MIGS patient-reported outcomes instrument ➤ ASCRS events
Get the latest ophthalmology news delivered to your inbox every Friday.